TVARDI THERAPEUTICS, INC. Deferred Revenue
TVARDI THERAPEUTICS, INC. (TVRD) had Deferred Revenue of $89.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Balance Sheet › Liabilities › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2016-03-11
- 2015-06-30: Deferred Revenue, Current $89.00K.
- 2015-03-31: Deferred Revenue, Current $963.00K.
- 2014-12-31: Deferred Revenue, Current $1.45M.
- 2014-09-30: Deferred Revenue, Current $1.94M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2015-06-30 | $89.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $963.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $1.45M 10-K · filed 2016-03-11 |
| 2014-09-30 | $1.94M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.07M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $3.42M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $3.48M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |